Active

VERZELE PHARMA ZWALM

Switched

BE0475231407

Rechtspersoon Private limited company 1 establishment

Diependale 8, 9700 Oudenaarde Detailhandel in farmaceutische producten

Active for

25 year, 2 months

Financials

Financial year 2025

Gross margin

€ 76,445

▼ 45% vs 2024

Profit

Healthy

€ 17,048

▼ 63% vs 2024

Debts

Low

€ 247,924

▼ 20% vs 2024

VERZELE PHARMA ZWALM from Oudenaarde, company number BE0475231407, closed financial year 2025 with a result of € 17,048 after tax. For that financial year VERZELE PHARMA ZWALM recorded a gross margin of € 76,445 and equity of € 183,267. Compared with financial year 2024, the result moved from € 45,541 to € 17,048. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What happened at VERZELE PHARMA ZWALM?

What happened at VERZELE PHARMA ZWALM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 17,048 (▼ 63% vs 2024). filed late Source: NBB ↗
  • New establishment in Zwalm. KBO
  • Start of the company according to the CBE. KBO

In short

From € 1,008 profit in 2021 to € 17,048 profit in 2025.

Paid € 9,386 in corporate taxes since 2021.

Best year ever: 2024, with € 45,541 profit.

On average € 120,600 of value added per employee in 2022.

A new publication or filing at VERZELE PHARMA ZWALM? We notify you, reason included.

Follow VERZELE PHARMA ZWALM

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Philippe Verzele
VERZELE PHARMA ZWALM
+1

Behind VERZELE PHARMA ZWALM are Philippe Verzele and Conrad Pharma BV. The same people are also behind GEVA PHARMA, Conrad Pharma, DECAPHAR and VERZELE PHARMA.

See the full network in the app

Directors

According to the 2025 annual accounts

Philippe Verzele

Director

Also active at: GEVA PHARMA, Conrad Pharma, DECAPHAR +1 more

Conrad Pharma BV

Director · represented by Vanessa Pluym

Also active at: GEVA PHARMA, DECAPHAR, VERZELE PHARMA

Establishments

Establishment units

Physical locations of this company

Registered office

Diependale 8

9700 Oudenaarde

2.194.688.643

Heufkensstraat(SDB) 129

9630 Zwalm

Active since 1 January 2011

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0475.231.407
VAT number
BE 0475.231.407
Registered office
Diependale 8, 9700 Oudenaarde
Names & denominations
VERZELE PHARMA ZWALM
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
6 July 2001
Peppol
Active · Active since 19 Nov 2025
Activities · NACE

Detailhandel in farmaceutische producten

Activiteiten van holdings

Managementactiviteiten van holdings

Holdings

Frequently asked questions

What is the enterprise number of VERZELE PHARMA ZWALM?
The enterprise number of VERZELE PHARMA ZWALM is BE0475231407.
What is the address of VERZELE PHARMA ZWALM?
The registered office of VERZELE PHARMA ZWALM is located at Diependale 8, 9700 Oudenaarde.
When was VERZELE PHARMA ZWALM founded?
VERZELE PHARMA ZWALM was founded on 6 July 2001.
What is the main activity of VERZELE PHARMA ZWALM?
The main activity of VERZELE PHARMA ZWALM is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does VERZELE PHARMA ZWALM have a website?
No website is currently known for VERZELE PHARMA ZWALM.
How much profit did VERZELE PHARMA ZWALM make in 2025?
VERZELE PHARMA ZWALM posted a profit after taxes of € 17,048 in financial year 2025.
What is the revenue of VERZELE PHARMA ZWALM?
As a small company, VERZELE PHARMA ZWALM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 76,445.
Where can I find the annual accounts of VERZELE PHARMA ZWALM?
VERZELE PHARMA ZWALM files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of VERZELE PHARMA ZWALM?
According to the 2025 annual accounts, the directors of VERZELE PHARMA ZWALM are: Philippe Verzele, Conrad Pharma BV.
Who owns VERZELE PHARMA ZWALM?
Behind VERZELE PHARMA ZWALM are Philippe Verzele and Conrad Pharma BV. The same people are also behind GEVA PHARMA, Conrad Pharma, DECAPHAR and VERZELE PHARMA.